English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/123012
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Cerebrospinal fluid Presenilin-1: a potential new biomarker for Alzheimer’s disease

AuthorsSáez-Valero, Javier
Issue Date23-Jun-2014
CitationThe Alzheimer's Disease Congress (2014)
AbstractPresenilin-1 (PS1) is the active component of the γ-secretase complex, and its presence in cerebrospinal fluid (CSF) has not been measured to date. Recently we have demonstrated that PS1 is present in CSF as 100–150-kDa hetero-complexes containing both the N- and C-terminal fragments of the protein, as well other γ-secretase components, but differ from active γ-secretase membrane-complexes. Particularly, the levels of the highly stable PS1 complexes are increased in CSF samples from Alzheimer’s disease (AD) cases, suggesting potential value as a biomarker for AD. Estimation of PS1 CSF levels may be useful to challenge the disease-modifying effects of newer Alzheimer’s therapy
DescriptionCominicación a congreso presentada en The 2014 Alzheimer's Disease Congress: Biomarker Discovery and Assay Development, celebrado en Londres del 23 al 25 de junio de 2014
URIhttp://hdl.handle.net/10261/123012
Appears in Collections:(IN) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.